News & Events

Agency Testimony

This section includes testimony by FDA officials before House and Senate Committees and Subcommittees.

08/19/2010 The BP Oil Spill: Accounting for the Spilled Oil and Ensuring the Safety of Seafood from the Gulf
Donald W. Kraemer, before the House Committee on Energy and Commerce, Subcommitee on Energy and Environment

07/22/2010 Direct-to-Consumer Genetic Testing and the Consequences to the Public
Jeffrey Shuren, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
07/21/2010 Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures
Jesse L. Goodman, M.D., M.P.H., before the Senate Committee on Health, Education, Labor and Pensions
07/14/2010 Antibiotic Resistance and the Use of Antibiotics in Animal Agriculture
Joshua M. Sharfstein, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health

06/23/2010 FDA's Efforts on Rare and Neglected Diseases
Jesse L. Goodman, M.D., M.P.H., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
06/16/2010 HHS Actions to Identify and Address Health Effects of the BP Oil Spill
Michael R. Taylor, J.D., before the House Committee on Energy and Commerce, Subcommittee on Health
06/15/2010 Evaluating the Health Impacts of the Gulf of Mexico Oil Spill
Michael R. Taylor, J.D., before the Senate Committee on Health, Education, Labor and Pensions
06/09/2010 Promoting the Development of Antibiotics and Ensuring Judicious Use in Humans
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health

05/27/2010 Johnson and Johnson's Recall of Children's Tylenol and Other Children's Medicines Joshua M. Sharfstein, M.D., before the House Committee on Oversight and Government Reform
05/26/2010 Oversight of Dietary Supplements
Joshua M. Sharfstein, M.D., before the Senate Special Committee on Aging
05/06/2010 The Role and Performance of FDA in Ensuring Food Safety
Michael R. Taylor, before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigation

04/13/2010 Regulation of Pseudoephedrine Charles J. Ganley, M.D., before the Senate Caucus on International Narcotics Control

03/10/2010 Drug Safety: An Update from FDA
Joshua M. Sharfstein, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health
03/10/2010 President's Fiscal Year 2011 Budget Request for the FDA Margaret A. Hamburg, M.D., before the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
03/09/2010 The President's Fiscal Year 2011 Budget Request for FDA Margaret A. Hamburg, M.D., before the Senate Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies

Office of the Commissioner

10903 New Hampshire Avenue

White Oak 32

Rm. 2346

Silver Spring, MD 20993